Literature DB >> 19521235

Inhibition of MEK sensitizes paclitaxel-induced apoptosis of human colorectal cancer cells by downregulation of GRP78.

Nizar M Mhaidat1, Feras Q Alali, Sina M Matalqah, Ismail I Matalka, Saied A Jaradat, Nour A Al-Sawalha, Rick F Thorne.   

Abstract

Here we report that paclitaxel induces variable degrees of apoptosis in human colorectal cancer cells. Paclitaxel induces multiple arms of the endoplasmic reticulum stress response, including upregulation of the 78-kDa glucose-regulatory protein (GRP78) and eukaryotic initiation factor alpha phosphorylation. Inhibition of the MEK/ERK pathway sensitized colorectal cancer cells to paclitaxel-induced apoptosis. A similar result was obtained by the inhibition of GRP78 using small interfering RNA molecules. Knockdown of MEK resulted in a significant downregulation of paclitaxel-induced upregulation of GRP78 indicating that activation of GRP78 is a downstream event of MEK/ERK pathway activation. These results indicate that GRP78 might be a novel mechanism underlying the resistance of colorectal cancer cells to microtubule-targeting drugs. A combination of compounds capable of suppressing GRP78 might be a golden approach for improving the effectiveness of taxanes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521235     DOI: 10.1097/CAD.0b013e32832e3120

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  13 in total

1.  Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.

Authors:  Marco Ragusa; Luisa Statello; Marco Maugeri; Alessandra Majorana; Davide Barbagallo; Loredana Salito; Mariangela Sammito; Manuela Santonocito; Rosario Angelica; Andrea Cavallaro; Marina Scalia; Rosario Caltabiano; Giuseppe Privitera; Antonio Biondi; Maria Di Vita; Alessandro Cappellani; Enrico Vasquez; Salvatore Lanzafame; Elisabetta Tendi; Salvatore Celeste; Cinzia Di Pietro; Francesco Basile; Michele Purrello
Journal:  J Mol Med (Berl)       Date:  2012-06-04       Impact factor: 4.599

2.  Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.

Authors:  Francesca Maddalena; Lorenza Sisinni; Giacomo Lettini; Valentina Condelli; Danilo Swann Matassa; Annamaria Piscazzi; Maria Rosaria Amoroso; Giuseppe La Torre; Franca Esposito; Matteo Landriscina
Journal:  Mol Oncol       Date:  2013-05-02       Impact factor: 6.603

3.  Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis.

Authors:  Khaled Aljarrah; Nizar M Mhaidat; M-Ali H Al-Akhras; Ahmad N Aldaher; Ba Albiss; Khaled Aledealat; Fawzi M Alsheyab
Journal:  World J Surg Oncol       Date:  2012-04-25       Impact factor: 2.754

4.  Inhibition of cancer cell proliferation and apoptosis-inducing activity of fungal taxol and its precursor baccatin III purified from endophytic Fusarium solani.

Authors:  Balabhadrapatruni Vsk Chakravarthi; Ramanathan Sujay; Gini C Kuriakose; Anjali A Karande; Chelliah Jayabaskaran
Journal:  Cancer Cell Int       Date:  2013-10-23       Impact factor: 5.722

5.  Astragalus saponins modulates colon cancer development by regulating calpain-mediated glucose-regulated protein expression.

Authors:  Yue Wang; Kathy K Auyeung; Xiaoyu Zhang; Joshua K Ko
Journal:  BMC Complement Altern Med       Date:  2014-10-15       Impact factor: 3.659

6.  WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.

Authors:  Szymon Janczar; Jaya Nautiyal; Yi Xiao; Edward Curry; Mingjun Sun; Elisa Zanini; Adam Jw Paige; Hani Gabra
Journal:  Cell Death Dis       Date:  2017-07-27       Impact factor: 8.469

7.  PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.

Authors:  Iris C Salaroglio; Elisa Panada; Enrico Moiso; Ilaria Buondonno; Paolo Provero; Menachem Rubinstein; Joanna Kopecka; Chiara Riganti
Journal:  Mol Cancer       Date:  2017-05-12       Impact factor: 27.401

Review 8.  New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets.

Authors:  Pooneh Mokarram; Mohammed Albokashy; Maryam Zarghooni; Mohammad Amin Moosavi; Zahra Sepehri; Qi Min Chen; Andrzej Hudecki; Aliyeh Sargazi; Javad Alizadeh; Adel Rezaei Moghadam; Mohammad Hashemi; Hesam Movassagh; Thomas Klonisch; Ali Akbar Owji; Marek J Łos; Saeid Ghavami
Journal:  Autophagy       Date:  2017-02-23       Impact factor: 16.016

9.  LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions.

Authors:  Cristina Barbagallo; Duilia Brex; Angela Caponnetto; Matilde Cirnigliaro; Marina Scalia; Antonio Magnano; Rosario Caltabiano; Davide Barbagallo; Antonio Biondi; Alessandro Cappellani; Francesco Basile; Cinzia Di Pietro; Michele Purrello; Marco Ragusa
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-02       Impact factor: 8.886

10.  GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment.

Authors:  Annat Raiter; Julia Lipovetzki; Ido Lubin; Rinat Yerushalmi
Journal:  BMC Cancer       Date:  2020-04-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.